Tag: Cancer: Throat
Persistent Opioid Use High in Head, Neck Cancer Patients
Opioid use before treatment, tobacco use are risk factors for ongoing opioid use
Pembrolizumab Promising for Metastatic Head, Neck SCC
Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma
Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer
Toxicity similar in two treatment groups at 24 months, but worse tumor control with cetuximab
One in Five Readmitted After Head, Neck Cancer Reconstruction
Both sociodemographic and clinical features up the rate of readmission
Head and Neck Cancer Survivors Have Increased Suicide Risk
Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers
The American Society for Radiation Oncology, Oct. 21-24
The 60th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology...
ASTRO: Oropharynx CA Survival Rates Worse With RT/Cetuximab
Inferior overall and progression-free survival for radiation/cetuximab versus radiation/cisplatin
Marijuana May Improve Quality of Life in Head and Neck Cancer
Some significant benefits observed in quality of life domains for patients with newly diagnosed HNC
Older Adults Increasingly Have HPV+ Oropharyngeal Cancers
Regardless of age, favorable survival conferred by an HPV-positive tumor status
ASCO: Undertreatment Seen for Women With Head & Neck Cancer
Female patients are less likely to receive intensive chemo, radiation; increased risk for death from HNC
